Vir Biotechnology (VIR) Non Operating Income (2018 - 2026)

Vir Biotechnology's Non Operating Income history runs 9 years deep, the most recent figure standing at $6.8 million for Q1 2026.

• In Q1 2026, Non Operating Income fell 63.63% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $48.4 million (up 190.42% YoY), while the FY2025 annual figure was $41.6 million, up 1971.14% from the prior year.
• Non Operating Income came in at $6.8 million for Q1 2026 at Vir Biotechnology, down from $41.6 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $41.6 million in Q4 2025 to a low of -$109.2 million in Q4 2022.
• A 5-year average of -$3.0 million and a median of $226000.0 in 2025 frame the typical range for Non Operating Income.
• Across the five-year window, Non Operating Income slumped 1101.06% in 2022 and soared 8327.67% in 2025, its largest moves.
• Vir Biotechnology's Non Operating Income stood at -$109.2 million in 2022, then surged by 116.72% to $18.3 million in 2023, then plunged by 102.77% to -$506000.0 in 2024, then jumped by 8327.67% to $41.6 million in 2025, then plunged by 83.75% to $6.8 million in 2026.
• According to Business Quant data, Non Operating Income over the past three periods registered $6.8 million, $41.6 million, and -$228000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison